Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 3
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Development of an Inactivated Vaccine against SARS CoV-2.
Pavel STI, Yetiskin H, Uygut MA, Aslan AF, Aydın G, İnan Ö, Kaplan B, Ozdarendeli A. Pavel STI, et al. Among authors: yetiskin h. Vaccines (Basel). 2021 Nov 2;9(11):1266. doi: 10.3390/vaccines9111266. Vaccines (Basel). 2021. PMID: 34835197 Free PMC article.
Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
Taşlı NP, Gönen ZB, Kırbaş OK, Gökdemir NS, Bozkurt BT, Bayrakcı B, Sağraç D, Taşkan E, Demir S, Ekimci Gürcan N, Bayındır Bilgiç M, Bayrak ÖF, Yetişkin H, Kaplan B, Pavel STI, Dinç G, Serhatlı M, Çakırca G, Eken A, Aslan V, Yay M, Karakukcu M, Unal E, Gül F, Basaran KE, Ozkul Y, Şahin F, Jones OY, Tekin Ş, Özdarendeli A, Cetin M. Taşlı NP, et al. Among authors: yetiskin h. Front Immunol. 2022 Mar 24;13:824378. doi: 10.3389/fimmu.2022.824378. eCollection 2022. Front Immunol. 2022. PMID: 35401544 Free PMC article.
Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants.
Mamedov T, Yuksel D, Gurbuzaslan I, Ilgin M, Gulec B, Mammadova G, Ozdarendeli A, Pavel STI, Yetiskin H, Kaplan B, Uygut MA, Hasanova G. Mamedov T, et al. Among authors: yetiskin h. Front Plant Sci. 2023 Aug 2;14:1202570. doi: 10.3389/fpls.2023.1202570. eCollection 2023. Front Plant Sci. 2023. PMID: 37600182 Free PMC article.
Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19.
Mamedov T, Yuksel D, Ilgın M, Gürbüzaslan I, Gulec B, Mammadova G, Ozdarendeli A, Yetiskin H, Kaplan B, Islam Pavel ST, Uygut MA, Hasanova G. Mamedov T, et al. Among authors: yetiskin h. Vaccines (Basel). 2021 Nov 17;9(11):1337. doi: 10.3390/vaccines9111337. Vaccines (Basel). 2021. PMID: 34835268 Free PMC article.
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020.
Alm E, Broberg EK, Connor T, Hodcroft EB, Komissarov AB, Maurer-Stroh S, Melidou A, Neher RA, O'Toole Á, Pereyaslov D; WHO European Region sequencing laboratories and GISAID EpiCoV group; WHO European Region sequencing laboratories and GISAID EpiCoV group*. Alm E, et al. Euro Surveill. 2020 Aug;25(32):2001410. doi: 10.2807/1560-7917.ES.2020.25.32.2001410. Euro Surveill. 2020. PMID: 32794443 Free PMC article.
Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials.
Ozdarendeli A, Sezer Z, Pavel STI, Inal A, Yetiskin H, Kaplan B, Uygut MA, Bayram A, Mazicioglu M, Unuvar GK, Yuce ZT, Aydin G, Aslan AF, Kaya RK, Koc RC, Ates I, Kara A. Ozdarendeli A, et al. Among authors: yetiskin h. Vaccine. 2023 Jan 9;41(2):380-390. doi: 10.1016/j.vaccine.2022.10.093. Epub 2022 Nov 22. Vaccine. 2023. PMID: 36460536 Free PMC article.
11 results